Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Maharaj Institute of Immune Regenerative Medicine (MIIRM) is a specialized clinical research and treatment center focused on precision medicine and immune system regeneration. Based in Boynton Beach, Florida, the institute was founded by Dr. Dipnarine Maharaj to advance the use of adult stem cells and immunotherapies for complex conditions including cancer, autoimmune diseases, and chronic inflammation. MIIRM is known for its 'Immune System Banking' platform, which enables the collection and cryopreservation of healthy immune cells for future therapeutic use. The institute conducts clinical trials on innovative treatments such as Allogeneic White Cell Immunotherapy (AWIT) and has developed AI-driven tools like Reg-GPT to support regenerative medicine research. Operating as an FDA-registered outpatient facility, MIIRM emphasizes personalized care protocols designed to restore immune function and improve patient longevity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maharaj Institute of Immune Regenerative Medicine.